Yorkville Advisors logo

Yorkville Advisors

North America, New Jersey, United States, Mountainside

Description

Yorkville Advisors is a global investment manager headquartered in Mountainside, New Jersey, specializing in customized structured debt and equity investments. The firm primarily focuses on providing capital to small and mid-cap public companies across various sectors, including biotechnology, natural resources, and technology. Unlike traditional venture capital firms that typically invest in private startups, Yorkville Advisors engages in alternative financing structures, often serving as a capital provider for companies that may face challenges accessing conventional funding channels.

The firm's investment strategy frequently involves Private Investments in Public Equity (PIPEs), convertible notes, and equity lines of credit. These structures typically allow companies to raise capital by issuing securities that can be converted into common stock. A key characteristic of these arrangements is that conversion prices are often linked to the market performance of the underlying stock, which can lead to significant dilution for existing shareholders if the stock price declines. This approach positions Yorkville Advisors as a specialized financier for public entities seeking flexible capital solutions.

Yorkville Advisors' typical financing facilities, which represent their capital commitments, often range from approximately $10 million to $50 million. For example, public records indicate that the firm provided a $10 million convertible note facility to a company in the healthcare sector in 2010. In another instance, they extended a $50 million equity line to a different public entity in 2012. These figures illustrate the scale of their structured finance transactions, which are tailored to the specific capital needs of their public company clients. Their distinct focus on public market instruments differentiates them from early-stage venture capital investors.

Investor Profile

Yorkville Advisors has backed more than 53 startups, with 14 new investments in the last 12 months alone. The firm has led 37 rounds, about 70% of its total and boasts 31 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Post Ipo Debt, Seed rounds (top funding stages).
  • Majority of deals are located in United States, Canada, Germany.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 13 rounds in the past year.
  • Typical check size: $10M – $50M.

Stage Focus

  • Post Ipo Equity (66%)
  • Post Ipo Debt (26%)
  • Seed (4%)
  • Series Unknown (4%)

Country Focus

  • United States (57%)
  • Canada (11%)
  • Germany (8%)
  • Israel (6%)
  • United Kingdom (4%)
  • Switzerland (4%)
  • Hong Kong (4%)
  • Sweden (2%)
  • France (2%)
  • China (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Electric Vehicle
  • Biopharma
  • Manufacturing
  • Genetics
  • Therapeutics
  • Pharmaceutical
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yorkville Advisors frequently co-invest with?

Goldman Sachs Asset Management
North America, New York, United States, New York
Co-Investments: 1
TC
North America, New York, United States, New York
Co-Investments: 1
GS Growth
North America, New York, United States, New York
Co-Investments: 1
PSP Investments
North America, Ontario, Canada, Ottawa
Co-Investments: 1
European Investment Bank
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
AG
North America, New York, United States, New York
Co-Investments: 1
NEC Corporation
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1

What are some of recent deals done by Yorkville Advisors?

MediciNova

San Diego, California, United States

MediciNova is a biopharmaceutical company that acquires and develops novel, small-molecule therapeutics.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityJul 31, 2025
Amount Raised: $30,000,000
Rein Therapeutics

Austin, Texas, United States

Rein Therapeutics is a biopharmaceutical company that is developing novel medicines for better treatment of patients.

BiopharmaHealth CareTherapeutics
Post Ipo EquityJul 30, 2025
Amount Raised: $21,000,000
NOVONIX

Bedford, Nova Scotia, Canada

NOVONIX is a developer and supplier of high-performance materials and technologies for the global lithium-ion battery industry.

Clean EnergyCleanTechManufacturing
Post Ipo DebtJul 23, 2025
Amount Raised: $23,275,000
ESS

Wilsonville, Oregon, United States

ESS is an energy storage company that designs and produces iron flow batteries for commercial and utility-scale energy storage applications.

ElectronicsEnergyEnergy ManagementEnergy StorageRenewable Energy
Post Ipo EquityJul 11, 2025
Amount Raised: $25,000,000
ESS

Wilsonville, Oregon, United States

ESS is an energy storage company that designs and produces iron flow batteries for commercial and utility-scale energy storage applications.

ElectronicsEnergyEnergy ManagementEnergy StorageRenewable Energy
Post Ipo DebtJul 11, 2025
Amount Raised: $1,700,000
Predictive Oncology

Eagan, Minnesota, United States

Predictive Oncology is working with the pharmaceutical, diagnostic, and biotech industries to develop customizable assessment methods.

Health CareHealth DiagnosticsMedicalOncologyPharmaceutical
Post Ipo EquityJul 8, 2025
Amount Raised: $10,000,000
Webull Corporation

St. Petersburg, Florida, United States

Webull Corporation is a technology-driven financial services company

Financial ExchangesFinancial ServicesImpact InvestingSoftwareVenture Capital
Post Ipo EquityJul 3, 2025
Amount Raised: $1,000,000,000
Luminar

Orlando, Florida, United States

Luminar is an autonomous vehicle and lidar technology company for passenger cars, commercial trucking, and robo-taxi.

AutomotiveAutonomous VehiclesSensorSoftware
Post Ipo EquityMay 21, 2025
Amount Raised: $35,000,000
Plug Power

Latham, New York, United States

Plug Power is a provider of clean hydrogen and zero-emission fuel cell solutions.

EnergyFuel CellIndustrialManufacturingOil and Gas
Post Ipo DebtApr 28, 2025
Amount Raised: $525,000,000
Vivoryon Therapeutics

Halle An Der Saale, Sachsen-Anhalt, Germany

Vivoryon is a clinical stage company focused on bringing first-in-class therapies to patients suffering from age-related diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Post Ipo EquityApr 24, 2025
Amount Raised: $17,079,536